Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paolo Cataldo"'
Autor:
Salvatore Arrotti, Fabio Alfredo Sgura, Daniel Enrique Monopoli, Valerio Siena, Giulio Leo, Vernizia Morgante, Paolo Cataldo, Paolo Magnavacchi, Davide Gabbieri, Vincenzo Guiducci, Giorgio Benatti, Luigi Vignali, Giuseppe Boriani, Rosario Rossi
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 6, p 228 (2023)
Background: Transcatheter aortic valve implantation (TAVI) has developed as an alternative to surgery for symptomatic high-risk patients with aortic stenosis (AS). An important complication of TAVI is acute kidney injury. The purpose of the study was
Externí odkaz:
https://doaj.org/article/210d7c884369481e9ecfa4be828e16f6
Autor:
Niccolo Bonini, Alessandro Albini, Andrea Venturelli, Anna Maisano, Jozef Luli, Marco Vitolo, Jacopo Francesco Imberti, Anna Chiara Valenti, Ilaria Righelli, Paolo Cataldo, Federico Muto, Alberto Tosetti, Giuseppe Boriani
Publikováno v:
European Heart Journal Supplements. 24
Background and aim of the study There is a rising interest in real-world data about Sacubitril/Valsartan (Sa/Va) treatment, especially for the renal outcomes in patients treated with low (24/26 mg bid), mid (49/51 mg bid) and high (97/103 mg bid) dos
Autor:
Marco Vitolo, Davide A. Mei, Paolo Cimato, Niccolò Bonini, Jacopo F. Imberti, Paolo Cataldo, Matteo Menozzi, Tommaso Filippini, Marco Vinceti, Giuseppe Boriani
Publikováno v:
Current Problems in Cardiology. :101789
Autor:
Paolo Cataldo, Serena Foffi, Cristina Quarta, Giulia Taborchi, Fabrizio Salvi, Francesco Cappelli, Gioele Fabbri, Christian Gagliardi, Alessandra Ferlini, Sabrina Frusconi, Claudio Rapezzi, Simone Bartolini, Agnese Milandri, Raffaele Martone, Michele Mario Cinelli, Massimiliano Lorenzini, Maria Letizia Bacchi Reggiani, Federico Perfetto
Publikováno v:
European Journal of Heart Failure. 20:1417-1425
Aims Cardiac amyloidosis remains a great challenge for the cardiologist. One of the three main aetiological forms, transthyretin-related hereditary amyloidosis (ATTRm), can present with several phenotypes, depending mainly on the specific mutation. W